NF110: Open-label, Phase 1 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Project: Research project

Project Details

Description

NF110: Open-label, Phase 1 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
StatusActive
Effective start/end date4/23/208/15/25

Funding

  • University of Alabama at Birmingham

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.